Volume 24, Issue 6 (November-December 2019)

REVIEW ARTICLES

Gastric cancer: adjuvant chemotherapy versus chemoradiation. A clinical point of view

Calin Cainap, Catalin Vlad, Andrada Seicean, Ovidiu Balacescu, Radu Seicean, Anne-Marie Constantin, Loredana Balacescu, Ovidiu Crisan, Monica Mihaela Marta, Simona Cainap; pp 2209-2219 (Pubmed Abstract, PDF)

Pain in head and neck cancer patients: the role of gender

Chiara Bianchini, Virginia Corazzi, Mariasole Malagò, Tiziana Bellini, Francesco Stomeo, Andrea Ciorba, Stefano Pelucchi; pp 2220-2226 (Pubmed Abstract, PDF)

The axolotl model for cancer research: a mini-review

Sherif Suleiman, Pierre Schembri-Wismayer, Jean Calleja-Agius ; pp 2227-2231 (Pubmed Abstract, PDF)

Hyperprogression after immunotherapy: A comprehensive review

Muharrem Okan Cakir, Onder Kirca, Seyda Gunduz, Mustafa Ozdogan; pp 2232-2241 (Pubmed Abstract, PDF)

SPECIAL MOLECULAR REVIEW

Mechanisms of C-myc oncogenic activity in head and neck squamous cell carcinoma

Nicholas Mastronikolis, Vasileios Ragos, Efthymios Kyrodimos, Aristeidis Chrysovergis,Vasileios Papanikolaou,Stylianos Mastronikolis, Athanasios Stamatelopoulos,Evangelos Tsiambas; pp 2242-2244 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

LUNG CANCER

Efficacy and prognosis analysis of surgical treatment for bilateral synchronous multiple primary non-small cell lung cancer

Hengchi Chen, Qiang Fu, Kelin Sun; pp 2245-2252 (Pubmed Abstract, PDF)

Efficacy of on-pump coronary artery bypass grafting and stent implantation combined with surgery on lung cancer

Zhili Cao, Hao Huang, Yafu Zhou, Yinyin Li, Yegang Ma, Ningning Zhou; pp 2253-2259 (Pubmed Abstract, PDF)

A study on the efficacy of recombinant human endostatin combined with chemotherapy intreating advanced non-small-cell lung cancer

Xiaoping Yang, Xuekun Wang, Na Wang, Wenqing Jiang, Yue Li, Xinai Yang, Bin Yin; pp 2260-2266 (Pubmed Abstract, PDF)

A study on the efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced stage non-small cell lung cancer

Jian Zhao, Haibing Yu, Tianci Han, Wei Wang, Wei Tong, Xiangyu Zhu; pp 2267-2272 (Pubmed Abstract, PDF)

Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375

Nan Xu, Lixing Qiao, Liping Yin, Han Li; pp 2273-2279 (Pubmed Abstract, PDF)

LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin

Ting Wang, Xingping Tang, Yanchen Liu; pp 2280-2286 (Pubmed Abstract, PDF)

MiR-532-3p inhibits metastasis and proliferation of non-small cell lung cancer by targeting FOXP3

Wenhua Jiang, Liangda Zheng, Qingqing Yan, Lili Chen, Xianting Wang; pp 2287-2293 (Pubmed Abstract, PDF)

Cytokeratin 7 and thyroid transcription factor – 1 levels in patients with lung cancer complicated with superior vena cava syndrome and their correlation with clinicopathological characteristics

Liumei Tong, Huiliang Xu; pp 2294-2302 (Pubmed Abstract, PDF)

GYNECOLOGICAL CANCERS

Efficacy of bevacizumab combined with albumin-bound paclitaxel in the treatment of platinum-resistant recurrent ovarian cancer

Biao Liu, Ran An, Jianwei Yu; pp 2303-2309 (Pubmed Abstract, PDF)

Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway

Yibing Zhang, Yong Zhao, Yongwang Ran, Jianyou Guo, Haifeng Cui, Sha Liu; pp 2310-2315 (Pubmed Abstract, PDF)

Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway

Min Qiu, Chunyan Xue, Lingyan Zhang; pp 2316-2321 (Pubmed Abstract, PDF)

A study on changes and clinical significance of blood glucose, blood lipid and inflammation in patients with ovarian cancer

Guanghu Li, Kewei Zhang, Fangchao Gong, Haiguo Jin; pp 2322-2326 (Pubmed Abstract, PDF)

Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study

Veli Sunar, Vakkas Korkmaz, Serkan Akin, Deniz Can Guven, Zafer Arik, Ozturk Ates, Mukaddes Yılmaz, Ozan Yazici, Mehmet Mutlu Meydanli, Berna Oksuzoglu; pp 2327-2332 (Pubmed Abstract, PDF)

A meta-analysis on the diagnostic value of diffusion-weighted imaging on ovarian cancer

Guidong Dai, Kali Liang, Zhengyuan Xiao, Qin Yang, Shugen Yang; pp 2333-2340 (Pubmed Abstract, PDF)

MicroRNA-375 inhibits the growth, drug sensitivity and metastasis of human ovarian cancer cells by targeting PAX2 

Shuli Yang, Ruiqi Yang, Ruixin Lin, Lihui Si; pp 2341-2346 (Pubmed Abstract, PDF)

Acute toxicity of postoperative intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cervical cancer: The role of concomitant chemotherapy

Dragoslava Marjanovic, Vesna Plesinac-Karapandzic, Suzana Stojanovic Rundic, Aleksandar Tomasevic, Milan Saric3, Ivana Miskovic, Borko Nidzovic, Predrag Petrasinovic; pp 2347-2354 (Pubmed Abstract, PDF)

BREAST CANCER

Paclitaxel-induced hepatic steatosis in patients with breast cancer

Fatih Inci, Fatih Karatas; pp 2355-2360 (Pubmed Abstract, PDF)

Comparisons of P53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis

Yi Li, Xuexia Zhang, Jiliang Qiu, Ting Pang, Lin Huang, Qingan Zeng; pp 2361-2368 (Pubmed Abstract, PDF)

Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population

Martha Patricia Gallegos-Arreola, Guillermo Moisés Zúñiga-González, Luis Eduardo Figuera, Ana María Puebla-Pérez, Jorge Iván Delgado-Saucedo; pp 2369-2376 (Pubmed Abstract, PDF)

Association of LncRNA-GACAT3 with MRI features of breast cancer and its molecular mechanism

Haifeng Hu, Ying Wang, Tianyu Zhang, Chunyu Zhang, Ying Liu, Guoan Li, Dandan Zhou, Shengnan Lu; pp 2377-2384 (Pubmed Abstract, PDF)

LIVER CANCER

Retrospective study of TACE in the treatment of lobaplatin-induced thrombocytopenia in primary hepatocellular carcinoma

Yinzhang Lv, Anhui Xu, Nan Wang, Ketao Mu, Zi Wang, Lingyun Zhao, Yanrong Huang, Ling Peng, Kun Xiang, Daoyu Hu, Jianpin Qi; pp 2385-2393 (Pubmed Abstract, PDF)

Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound

Yu Wang, Zhidong Xuan, Xue Zheng, Ruoling Han, Li Zhou, Haixia Liu, Yongrong Liu; pp 2394-2401 (Pubmed Abstract, PDF)

CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124

Shuaimin Zhang, Yan Liu, Zhenhua Liu, Yi Zhang, Gen Chen, Keyue Li, Keli Tang; pp 2402-2410 (Pubmed Abstract, PDF)

Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis

Jianhua Fan, Sha He, Yi Zheng; pp 2411-2417 (Pubmed Abstract, PDF)

HEAD & NECK CANCER

Impact of different therapeutic regimens on survival of patients with nasopharyngeal carcinoma

Nikolaos ChristodoulopoulosNicholas MastronikolisEvangelos Tsiambas, Eleni Jelastopulu, Despοina SpyropoulouSpyridon Lygeros, Gerasimos DanielidesStylianos Mastronikolis, Theodoros A. Papadas; pp 2418-2422 (Pubmed Abstract, PDF)

Murrayanine exerts antiproliferative effects on human oral cancer cells through inhibition of AKT/mTOR and Raf/MEK/ERK signalling pathways in vitro and inhibits tumor growth in vivo

Hui Zhou, Hui li, Yan Cao, Xue Sang, Xin Liu; pp 2423-2428 (Pubmed Abstract, PDF)

Long non-coding RNA PCAT1 promotes cell migration and invasion in human laryngeal cancer by sponging miR-210-3p

Weiqun Hu, Na Dong, Jinqiao Huang, Ben Ye; pp 2429-2434 (Pubmed Abstract, PDF)

COLORECTAL CANCER

Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?

Yakup Ergun, Oznur Bal, Mutlu Dogan, Dogan Uncu; pp 2435-2441 (Pubmed Abstract, PDF)

Xanthohumol chalcone acts as a powerful inhibitor of carcinogenesis in drug-resistant human colon carcinoma and these effects are mediated via G2/M phase cell cycle arrest, activation of apoptotic pathways, caspase activation and targeting Ras /MEK/ERK pathway

Xiaokang Liu, LiJuan An, Yu Li, Yanwei Wang, Lei Zhao, Xi Lv, Jinyi Guo, Ai Lin Song; pp 2442-2447 (Pubmed Abstract, PDF)

Clinical significance of Leptin receptor (LEPR) and Endoglin (CD105) expressions in colorectal adenocarcinoma

Milena S. Vuletic, Velimir S. Milosevic, Snezana A. Jancic, Janko T. Zujovic, Miljan S. Krstic, Filip C. Vukmirovic; pp 2448-2457 (Pubmed Abstract, PDF)

CNS CANCER

IDH1 mutation promotes proliferation and migration of glioma cells via EMT induction

Jie Lu, Depei Li, Yu Zeng, Hai Wang, Wenfeng Feng, Songtao Qi, Lei Yu; pp 2458-2464 (Pubmed Abstract, PDF)

miR-3175 and miR-134 Affect Proliferation, Invasion and Apoptosis of Glioma Cells through PI3K/AKT Signaling Pathway

Running title: miR-3175 and miR-134 on Glioma Cells through PI3K/AKT Signaling Pathway

Aiqin Qi, Zhen Liu, Fengxia Jia, Chao Liu; pp 2465-2474 (Pubmed Abstract, PDF)

The VEGF gene polymorphism in glioblastoma may be a new prognostic marker of overall survival

Igor Djan, Silvija Lucic, Mladen Bjelan, Nada Vuckovic, Natasa Vucinic, Alessio Giuseppe Morganti, Mihajla Djan, Milos Lucic; pp 2475-2482 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

Successful reversal of severe liver function impairment with Brentuximab vedotin in multiply relapsed/refractory classical Hodgkin lymphoma

Nikolaos Spathas, Marina Belia, Theofanis Giannikos, Maria Arapaki, Maria Efstathopoulou, Gerassimos Tsourouflis, Gabriella Gainaru,

John Asimakopoulos, Panayiotis Tsaftaridis, Maria K. Angelopoulou, Eleni Plata, Kostas Konstantopoulos, Theodoros P. Vassilakopoulos; pp 2483-2489 (Pubmed Abstract, PDF)

An isoliquiritigenin derivative inhibited myeloma cells’ proliferation and its interactions with human serum albumin

Wei Cao, Le Fang, Zhaoxia Zhang, Jianing Xi; pp 2490-2498 (Pubmed Abstract, PDF)

GASTRIC CANCER

Cetuximab combined with cisplatin improves the prognosis of gastric cancer patients and its effect on P38 MAPK expression

Qiang Chen, Longhai Shen, Can Chen, Huan He, Yining Fu, Liang Xu, Yang Wang; 2499-2505 (Pubmed Abstract, PDF)

A comparative study on endoscopic submucosal dissection and laparoscopy-assisted radical gastrectomy in the treatment of early gastric carcinoma

Yun Zhao, Zhongming Deng, Hengping Li, Yi Wang, Wanli Zhang, Yong Xiao, Jing Huang; 2506-2513 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5

Hong Jiang, Yi Guo, Kanghua Huang, Rongxia Lu, Xiaohong Peng, Shaoxiong Lin; pp 2514-2522 (Pubmed Abstract, PDF)

Expression of Stathmin and vascular endothelial growth factor C in  esophageal cancer and their combined diagnostic value

Xianghui Luo, Yun Dai, Yanfei Cao; pp 2523-2530 (Pubmed Abstract, PDF)

PROSTATE CANCER

Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer

Junyi Chen, Fubo Wang, Huan Xu, Dong Chen, Weihui Liu, Jialiang Wang; pp 2531-2538 (Pubmed Abstract, PDF)

SMALL BOWEL CANCER

Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma

Xiaoyuan Li, Hongyan Ying, Yuejuan Cheng, Lin Zhao, Sun Zhao, Chunmei Bai, Jianfeng Zhou; pp 2539-2545 (Pubmed Abstract, PDF)

GASTROINTESTINAL STROMAL TUMORS

Perioperative application of midline catheter and PICC in Patients with gastrointestinal tumors

Fengying Tao, Xiaohe Wang, Jiumei Liu, Jing Li, Fengxiang Sui; pp 2546-2552 (Pubmed Abstract, PDF)

MISCELLANEOUS

Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis

Gaiying Zhang, Jianrong Cai; pp 2553-2559 (Pubmed Abstract, PDF)

An applicable method for PET/CT image quality assessment and comparison among three PET/CT systems with similar physical performance in cancer patients

Jian Tian, Kun Zhou, Zhaoheng Xie, Baixuan Xu, Jiahe Tian, Yingyin Chen, Xiaoyi Zhu, Qiushi Ren; pp 2560-2569 (Pubmed Abstract, PDF)

Visualization of dose distribution in Intraoperative Electron Beam Radiotherapy based on ultrasound images

Janusz Winiecki, Agnieszka Orzechowska, Sebastian Maleszka, Marta Biedka, Tomasz Wiśniewski, Sławomir Nowakowski, Roman Makarewicz; pp 2570-2576 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Infiltrating lobular breast carcinoma; is gastrointestinal endoscopy recommended for staging?

Kadri Altundag; p 2577 (Pubmed Abstract, PDF)

Some concerns about adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer

Kadri Altundag; p 2577 (Pubmed Abstract, PDF)

C-myc deregulation in pancreatic carcinomas

Leonidas Petrogiannopoulos, Athanasios Niotis, Theodoros Niotis, Evangelos Tsiambas; p 2578 (Pubmed Abstract, PDF)

All-oral (vinorelbin plus capecitabine) combination regimen might be preferable to oral vinoreline or weeky paclitaxel in estrogen receptor-positive, HER2-negative patients with visceral metastasis

Kadri Altundag; p 2578 (Pubmed Abstract, PDF)

Strict definition of inflammatory breast cancer should be revisited

Kadri Altundag (Pubmed Abstract, PDF)

Interaction of brivudine with capecitabine: A case of serious toxicity

Ioannis Drositis, Emmanuel Kontopodis, Emmanuel Saloustros, Nikolaos Androulakis; p 2579 (Pubmed Abstract, PDF)

Screening imaging of the brain might be considered in triple negative breast cancer patients receiving neo‐adjuvant chemotherapy with a high-risk score features

Kadri Altundag; p 2580 (Pubmed Abstract, PDF)

Efficacy of neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in luminal A or luminal B breast cancer patients: Does it matter?

Kadri Altundag; p 2581 (Pubmed Abstract, PDF)

Regular daily consumption of cruciferous vegetables may be effective for prevention and treatment of breast cancer by reactivating PTEN tumor suppressor

Kadri Altundag; pp 2581-2582 (Pubmed Abstract, PDF)

HISTORY OF ONCOLOGY

Arsenic powder in the treatment of cancer: the invention of French physician Pierre Alliot (1610-1685)

Marianna Karamanou, Konstantinos Laios, Gregory Tsoucalas, Spyros N. Michaleas, George Androutsos; pp 2583-2588 (Pubmed Abstract, PDF)

Reset link sent!

Link for password reset has been emailed to you. Please check your email.